Data / Drug companies / Hetero Drugs Limited
Hetero Drugs Limited: 134 products in the FDA NDC directory, labeler code 65977
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Hetero Drugs Limited (labeler code 65977) lists 134 products in the FDA National Drug Code Directory. By type: 134 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on September 9, 2022.
The request: Watch Hetero Drugs Limited (FDA labeler code 65977): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 65977
- Products in commercial distribution
- 134
- Packages
- 138
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule IV 1, Schedule V 2
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- January 1, 1982
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 134 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 134 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 132 | 98.5% |
| Liquid | 2 | 1.5% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Deucravacitinib | 65977-0170 | Powder | Bulk ingredients | September 9, 2022 |
| Mitapivat sulfate | 65977-0168 | Powder | Bulk ingredients | February 17, 2022 |
| Solriamfetol hydrochloride | 65977-0140 | Powder | Bulk ingredients | December 17, 2019 |
| Selenious acid | 65977-0146 | Powder | Bulk ingredients | April 30, 2019 |
| Amifampridine phosphate | 65977-0138 | Powder | Bulk ingredients | November 28, 2018 |
| Sodium zirconium cyclosilicate | 65977-0132 | Powder | Bulk ingredients | May 18, 2018 |
| Semaglutide | 65977-0165 | Powder | Bulk ingredients | December 5, 2017 |
| Deutetrabenazine | 65977-0123 | Powder | Bulk ingredients | April 3, 2017 |
| Ferric citrate | 65977-0161 | Powder | Bulk ingredients | September 5, 2014 |
| Desvenlafaxine succinate | 65977-0142 | Powder | Bulk ingredients | August 20, 2014 |
| Eliglustat tartrate (amorphous) | 65977-0155 | Powder | Bulk ingredients | August 19, 2014 |
| Eliglustat tartrate | 65977-0151 | Powder | Bulk ingredients | August 19, 2014 |
| Vasopressin | 65977-0163 | Powder | Bulk ingredients | April 17, 2014 |
| Apremilast | 65977-0119 | Powder | Bulk ingredients | March 21, 2014 |
| Lercanidipine hydrochloride | 65977-0099 | Powder | Bulk ingredients | December 31, 2013 |
| Ivabradine hydrochloride | 65977-0098 | Powder | Bulk ingredients | December 31, 2013 |
| Sucroferric oxyhydroxide | 65977-0153 | Powder | Bulk ingredients | November 27, 2013 |
| E70g3g5863 | 65977-0157 | Powder | Bulk ingredients | August 13, 2013 |
| Ferric carboxymaltose | 65977-0166 | Powder | Bulk ingredients | July 25, 2013 |
| Glycerol phenylbutyrate | 65977-0121 | Powder | Bulk ingredients | February 1, 2013 |
| Mirabegron | 65977-0133 | Powder | Bulk ingredients | June 28, 2012 |
| Mirabegron | 65977-0112 | Powder | Bulk ingredients | June 28, 2012 |
| Rivaroxaban | 65977-0139 | Powder | Bulk ingredients | July 1, 2011 |
| Rilpivirine hydrochloride | 65977-0104 | Powder | Bulk ingredients | May 20, 2011 |
| Roflumilast | 65977-0111 | Powder | Bulk ingredients | February 28, 2011 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.